| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |